Pediatric Psychopharmacology Clinical and Research Program, Massachusetts General Hospital, 55 Fruit Street, YAW 6900, Boston, MA, 02114, USA.
Eur Arch Psychiatry Clin Neurosci. 2013 Aug;263(5):379-84. doi: 10.1007/s00406-012-0369-9. Epub 2012 Sep 18.
The pilot study aimed at examining the neural glutamatergic activity in autism. Seven adolescent males (mean age: 14 ± 1.8; age range: 12-17 years) with intact intellectual capacity (mean IQ: 108 ± 14.26; IQ range: 85-127) suffering from autistic disorder and an equal number of age- and sex-matched healthy controls underwent a two-dimensional magnetic resonance spectroscopy scan at 4T. Results indicated significantly high glutamate (Glu) levels in the anterior cingulate cortex of autistic disorder versus control subjects (paired t test p = 0.01) and a trend for lower Glu in the right medial temporal lobe, which was not statistically different between the groups (paired t test p = 0.06). These preliminary findings support the glutamatergic dysregulation hypothesis in autism and need to be replicated in a larger sample.
这项初步研究旨在探讨孤独症的神经谷氨酸能活性。七名智力正常的青少年男性(平均年龄:14 ± 1.8;年龄范围:12-17 岁)患有孤独症障碍,他们与年龄和性别相匹配的健康对照组一样,在 4T 磁共振扫描仪上进行了二维磁共振波谱扫描。结果表明,孤独症患者的前扣带回皮质中的谷氨酸(Glu)水平显著升高,与对照组相比(配对 t 检验,p = 0.01),右侧内侧颞叶的 Glu 水平有下降趋势,但组间无统计学差异(配对 t 检验,p = 0.06)。这些初步发现支持孤独症的谷氨酸能失调假说,需要在更大的样本中进行复制。